Use of specific antiretroviral regimens among HIV-infected women in Italy at time of conception: 2001-2011

AIDS Patient Care and STDs

Volumn 26, Issue 8, 2012, Pages 439-443

  Floridia, Marco ^a   Ravizza, Marina ^b   Guaraldi, Giovanni ^c   Pinnetti, Carmela ^d   Martinelli, Pasquale ^e   Tamburrini, Enrica ^d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ENFUVIRTIDE; ETRAVIRINE; FOSAMPRENAVIR; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; MARAVIROC; NELFINAVIR; NEVIRAPINE; RALTEGRAVIR; SAQUINAVIR; STAVUDINE;

BIRTH DEFECT; CONCEPTION; DATA BASE; DRUG EXPOSURE; DRUG POTENCY; DRUG SAFETY; EUROPE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LETTER; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREGNANT WOMAN; TERATOGENICITY; UNSAFE SEX;

ANTI-HIV AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILIZATION; HIV PROTEASE INHIBITORS; HIV SEROPOSITIVITY; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ITALY; PREGNANCY; REVERSE TRANSCRIPTASE INHIBITORS; SENTINEL SURVEILLANCE;

EID: 84864653882     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0116     Document Type: Letter

References (13)

1. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. September 14, 2011;1-207. http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf (Last accessed January 10, 2012).
2. European AIDS Clinical Society Guidelines. Version 6.0, October 2011. www.europeanaidsclinicalsociety.org/guid2/index.html?ml=1 (Last accessed January 10, 2012).
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011;1-166. www.aidsinfo .nih.gov/ContentFiles/AdultandAdolescentGL.pdf (Last accessed January 10, 2012).
4. Finger JL, Clum GA, Trent ME. Desire for pregnancy and risk behavior in young HIV-positive women. AIDS Patient Care STDS 2012;26:173-180.
5. Loutfy M, Raboud J, Wong J, et al. High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: A retrospective study. HIV Med 2012;13:107-117.
6. Floridia M, Ravizza M, Tamburrini E, et al. Diagnosis of HIV infection in pregnancy: Data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect 2006; 134:1120-1107.
7. Baroncelli S, Tamburrini E, Ravizza M, et al. Pregnancy outcomes in women with advanced HIV infection in Italy. AIDS Patient Care STDs 2011;25:639-645.
8. Griner R, Williams PL, Read JS, et al. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Patient Care STDs 2011;25:385-394.
9. Girardi E, Vanacore P, Costa F, et al. Trends in HIV prevalence among pregnant women in Italy, 1994 to 2002. J Acquir Immune Defic Syndr 2006;41:361-364.
10. Scheuerle A, Tilson H. Birth defect classification by organ system: A novel approach to heighten teratogenic signalling in a pregnancy registry. Pharmacoepidemiol Drug Saf 2002;11:465-475.
11. Fundarò C, Genovese O, Rendeli C, et al. Myelomeningocele in a child with intrauterine exposure to efavirenz. AIDS 2002;16:299-300.
12. Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 2010;Mar 17;(3):CD008440.
13. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989-31 July 2011. Executive summary. www.apregistry.com/forms/exec- summary.pdf (Last accessed January 10, 2012).